Search

everythinglearnresearchcommunity

for

Search:↓

Frunevetmab injections in cats can cause severe itching and skin lesions.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Low-dose oral minoxidil effectively promotes hair growth but has associated risks.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Oral minoxidil may have more cardiovascular risks than topical minoxidil.

Finasteride use may increase depression and suicide risk, especially at 1 mg, so monitoring is advised.

Topical minoxidil may cause more side effects than currently listed, needing updated safety information.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Finasteride use for hair loss is linked to an increased risk of suicidal thoughts and a higher risk of suicide.

Finasteride, a hair loss drug, is linked to increased suicidal thoughts, particularly when used for hair loss.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Finasteride toxicity information is limited, poor quality, and biased.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.